Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea

被引：1
|
作者：
Camilleri, M. [1 ]
Acosta, A. [1 ]
机构：
[1] Mayo Clin, CENTER, Rochester, MN 55905 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 38卷 / 10期
关键词：
IRRITABLE-BOWEL-SYNDROME; MALABSORPTION;
D O I：
10.1111/apt.12487
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1320 / 1321
页数：2
相关论文
共 50 条
  • [1] EVALUATION OF FIBROBLAST GROWTH FACTOR 19 IN THE DIAGNOSIS OF BILE ACID DIARRHOEA
    Pattni, S.
    Dew, T.
    Srinivas, M.
    Basumani, P.
    Bardhan, K. D.
    Walters, J. R. F.
    GUT, 2011, 60 : A88 - A88
  • [2] Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients
    Chunxia Chang
    Jingjing Jiang
    Rui Sun
    Shenggen Wang
    Hong Chen
    Digestive Diseases and Sciences, 2022, 67 : 872 - 879
  • [3] A PROSPECTIVE STUDY OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH CHRONIC DIARRHOEA AND POSSIBLE BILE ACID MALABSORPTION
    Pattni, S.
    Dew, T.
    Walters, J. R. F.
    GUT, 2010, 59 : A48 - A48
  • [4] Downregulation of Serum and Distal Ileum Fibroblast Growth Factor19 in Bile Acid Diarrhoea Patients
    Chang, Chunxia
    Jiang, Jingjing
    Sun, Rui
    Wang, Shenggen
    Chen, Hong
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (03) : 872 - 879
  • [5] Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19
    Borup, Christian
    Syversen, Charlotte
    Bouchelouche, Pierre
    Damgaard, Morten
    Graff, Jesper
    Rumessen, Juri Johannes
    Munck, Lars Kristian
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (12) : 1399 - 1402
  • [6] STIMULATED EXPRESSION OF ILEAL FIBROBLAST GROWTH FACTOR 19 BY BILE ACIDS IS IMPAIRED IN PATIENTS WITH PRIMARY AND SECONDARY BILE ACID DIARRHOEA
    Nolan, J. D.
    Appleby, R. N.
    Madhan, G. K.
    Johnston, I. M.
    Sarah, K.
    Zhang, J. H.
    Walters, J.
    GUT, 2015, 64 : A19 - A19
  • [7] Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention
    Pattni, S. S.
    Brydon, W. G.
    Dew, T.
    Johnston, I. M.
    Nolan, J. D.
    Srinivas, M.
    Basumani, P.
    Bardhan, K. D.
    Walters, J. R. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (08) : 967 - 976
  • [8] Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
    Borup, C.
    Wildt, S.
    Rumessen, J. J.
    Bouchelouche, P. N.
    Graff, J.
    Damgaard, M.
    McQuitty, C.
    Rainteau, D.
    Munck, L. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1433 - 1442
  • [9] Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea
    Appleby, R. N.
    Bajor, A.
    Gillberg, P-G
    Graffner, H.
    Simren, M.
    Ung, K. A.
    Walters, J. R. F.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (03) : 380 - 388
  • [10] Evaluation of Fibroblast Growth Factor 19 in the Diagnosis of Bile Acid Diarrhea
    Pattni, Sanjeev S.
    Dew, Tracy
    Srinivas, Melpakkam
    Basumani, Pandurangan
    Bardhan, Karna D.
    Walters, Julian R.
    GASTROENTEROLOGY, 2011, 140 (05) : S284 - S284
12345